awd 26-06 has been researched along with pentagastrin in 1 studies
*Pentagastrin: A synthetic pentapeptide that has effects like gastrin when given parenterally. It stimulates the secretion of gastric acid, pepsin, and intrinsic factor, and has been used as a diagnostic aid. [MeSH]
*Pentagastrin: A synthetic pentapeptide that has effects like gastrin when given parenterally. It stimulates the secretion of gastric acid, pepsin, and intrinsic factor, and has been used as a diagnostic aid. [MeSH]
| Studies (awd 26-06) | Trials (awd 26-06) | Recent Studies (post-2010) (awd 26-06) | Studies (pentagastrin) | Trials (pentagastrin) | Recent Studies (post-2010) (pentagastrin) |
|---|---|---|---|---|---|
| 7 | 1 | 0 | 3,639 | 207 | 51 |
| Protein | Taxonomy | awd 26-06 (IC50) | pentagastrin (IC50) |
|---|---|---|---|
| Cholecystokinin receptor type A | Rattus norvegicus (Norway rat) | 0.8875 | |
| Gastrin/cholecystokinin type B receptor | Homo sapiens (human) | 0.001 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Feller, K; Gramatté, T; Terhaag, B | 1 |
1 trial(s) available for awd 26-06 and pentagastrin
| Article | Year |
|---|---|
[Clinico-pharmacologic studies with a M1 receptor antagonist (substance AWD 26-06) in a phase I clinical trial].
Topics: Adult; Anti-Ulcer Agents; Dibenzazepines; Dose-Response Relationship, Drug; Drug Evaluation; Gastric Acidity Determination; Gastric Mucosa; Humans; Male; Pentagastrin; Receptors, Muscarinic; Secretory Rate | 1988 |